Mayne Pharma Group Limited - Australian Company Profile

Company Type: Public Company

ASX Code: MYX

What does Mayne Pharma Group Limited do?

Mayne Pharma Group Limited is a locally owned public company, deriving revenue from the in-house and contract development, manufacture and distribution of branded and generic pharmaceutical products. The company employs over 850 people, operates in Australia and the United States, and is administered by its head office in Salisbury South, South Australia.

Mayne Pharma Group is listed on the ASX under the code MYX.

Mayne Pharma Group Limited - Products & Brands

Mayne Pharma Group develops and manufactures branded and generic products for sale in over 20 countries. Production is managed in Greenville, North Carolina in the United States and in Salisbury, South Australia.

Products include, but are not limited to:

Specialty Brands

  • Astrix capsules and tablets
  • Doryx capsules
  • Eryc capsules
  • Esgic tablets and capsules
  • Fabior (tazarotene) foam
  • Kapanol capsules
  • Licener single treatment
  • Lorcet tablets
  • Lozanoc capsules
  • Magnoplasm paste and Magnoplasm Splintex gel
  • Percutane pain relief cream and Percutane sports cream
  • Sorilux (calcipotriene) foam
  • Tri-Norinyl tablets
  • Urocarb tablets

Generic Products

  • Aspirin tablets
  • Doxycycline capsules
  • Ephedrine Hydrochloride MYX
  • Epoprostenol MYX
  • Erythromycin capsules
  • Noradrenaline MYX
  • Oxycodone IR tablets
  • Water for Injection MYX

Along with production branded under the Mayne Pharma name, the company also undertakes research & development and production of pharmaceutical products on a contract basis for external companies at its Greenville facility.

IBISWorld provides company profiles on the top 2,000 organisations that drive Australia’s economy.

LEARN MORE

Mayne Pharma Group Limited - Financial Statements

pie_chart Mayne Pharma Group Limited Financial Profit & Loss Account

BALANCE DATE6/30/20196/30/20186/30/20176/30/20166/30/2015
Sales Revenue525,2080.50.60.30.1
Other Revenue0000000000000000000000000
Total Revenue0000000000000000000000000
Cost of Goods Sold0000000000000000000000000
Depreciation0000000000000000000000000
R & D Expenditure0000000000000000000000000
lock To view Mayne Pharma Group Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Mayne Pharma Group Limited - Financial Ratios

pie_chart Mayne Pharma Group Limited Financial Growth

BALANCE DATE6/30/20196/30/20186/30/20176/30/20166/30/2015
Total Revenue Growth-0.84-11.91116.8688.733.24
Sales Revenue Growth0000000000000000000000000
EBITDA0000000000000000000000000
NPAT0000000000000000000000000
Shareholder's Funds0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000

pie_chart Mayne Pharma Group Limited Financial Ratios

BALANCE DATE6/30/20196/30/20186/30/20176/30/20166/30/2015
Return on Revenue (ROR) (%)-53.0-25.014.613.35.2
Return on Shareholders’ Funds (ROSF) (%)0000000000000000000000000
Return on Assets (ROA) (%)0000000000000000000000000
Profit Margin (%)0000000000000000000000000
Revenue per Employee ($’000 per person)0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000
lock To view Mayne Pharma Group Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Mayne Pharma Group Limited's Competitive Environment

Mayne Pharma Group Limited operates in the following industries:

Mayne Pharma Group Limited's main competitors:

  • CSL Limited
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
lock To view Mayne Pharma Group Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Company Profiles - table of contents

A high-level overview of Mayne Pharma Group Limited’s registered business details, a company synopsis, history and background, as well as Mayne Pharma Group Limited’s main brands and products.

We outline the Mayne Pharma Group Limited’s key personnel by position type and title.

Get a full view of Mayne Pharma Group Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Understand the main operating divisions of Mayne Pharma Group Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Mayne Pharma Group Limited operates in.

Understand the competitive threats and opportunities within the industries Mayne Pharma Group Limited operates in. Gain insight into the industry trends and competitive forces that Mayne Pharma Group Limited is exposed to.

We outline Mayne Pharma Group Limited’s ultimate parent and largest shareholders.

A list of Mayne Pharma Group Limited’s associated companies, holding company and trusts.

Where available, we provide details of Mayne Pharma Group Limited’s banker, external auditor, insurance broker, internal auditor, solicitor and telecommunication provider.

Purchase to Read Full Report

100% Money Back Guarantee Digicert Trusted

Included in Report

  • Company History & Synopsis
    Company History & Synopsis
  • Company Financial Statements
    Company Financial Statements
  • Financial Ratios
    Financial Ratios
  • Industry Averages
    Industry Averages
  • Competitive Landscape
    Competitive Landscape
  • Key Company Personnel
    Key Company Personnel
  • Subsidiaries & Ownership Structure
    Subsidiaries & Ownership Structure

Why buy this company profile on Mayne Pharma Group Limited?

IBISWorld company profiles enable you to:

  • Understand a company’s competitive landscape
  • Identify industry trends a company is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key company personnel

The profile on Mayne Pharma Group Limited includes:

  • Company History and Synopsis
  • Overview of Brands and Products
  • Company Financial Statements and Financial Ratios
  • Key Company Personal
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

IBISWorld provides profiles on 2,000 private and public Australian companies and reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal
clear